Stay updated with breaking news from Bipolar Disorder Research Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adults with resistant schizophrenia have significant gut microbiome differences vs their counterparts who respond to treatment, a new finding that may be driven by clozapine treatment.
The investigational antipsychotic KarXT is effective in reducing positive and negative symptoms of schizophrenia, with a favorable side-effect profile in the pivotal EMERGENT-2 trial.